Caterina Dianzani

COVID‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action

Claudio Conforti, Roberta Giuffrida, Caterina Dianzani et al. · Dermatologic Therapy · 2020 · 102 citations · Full text

Immunodeficiencies, Immunology, Pharmacotherapy +24

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma

Marta Betti, Anna Aspesi, Alessandra Biasi et al. · Cancer Letters · 2016 · 74 citations · Full text

Medicine, Melanoma, Pathology +5

The detection of human papillomavirus DNA in skin tags

Caterina Dianzani, Stefano Calvieri, Alessandra Pierangeli et al. · British Journal of Dermatology · 1998 · 59 citations

Human Papillomavirus Vaccines, Hpv Types, Histopathology +13

Topical Azithromycin as a Novel Treatment for Ocular Rosacea

Flavio Mantelli, Antonio Di Zazzo, Marta Sacchetti et al. · Ocular Immunology and Inflammation · 2013 · 45 citations

<scp>COVID</scp> ‐19 and <scp>SARS</scp> : Differences and similarities

Antonio Caldaria, Claudio Conforti, Nicola di Meo et al. · Dermatologic Therapy · 2020 · 35 citations · Full text

Virus Epidemiology, Surgery, Covid-19 Epidemiology +26